BioInnovation Institute Allocates €7.8M to Six Deeptech Startups

The BioInnovation Institute (BII) has allocated €7.8 million in additional funding to six companies, supporting their efforts to commercialise deeptech across healthcare, agriculture, and sustainable energy. Each company will receive €1.3 million, as reported by Tech.eu.

This significant investment underscores a broader commitment to translating scientific breakthroughs into market-ready solutions. The funding targets technologies with high potential for societal impact. In healthcare, this aligns with ongoing efforts to innovate diagnostics and treatment methods. For instance, the closed FADEQ project, funded with €2.5 million, focused on automating cell-free DNA extraction and quantification for liquid biopsies, a crucial area for cancer and prenatal screening. Such advancements reduce the need for a skilled workforce and simplify sample logistics, addressing pre-analytical challenges in diagnostics.

Beyond healthcare, the BII's support extends to agricultural and sustainable energy innovations. This includes technologies that could leverage advanced bioengineered solutions, similar to the objectives of the signed OptiPlex project. OptiPlex explores the commercial feasibility of a continuous stirred tank reactor for optimising complex enzymatic pathways, offering an alternative to traditional bioengineered organisms for production.

This initiative also reflects a wider European focus on strengthening biotechnology innovation ecosystems. The closed BIOCONNECT project, for example, aimed to develop an action plan to foster a robust Baltic Region innovation ecosystem in biotechnology and synthetic biology. BIOCONNECT highlighted the potential of a strong bioeconomy to reinforce EU sustainability goals and drive new applications, a vision consistent with BII's latest funding round.

What this means: This funding injection by BII is a direct push to accelerate the commercialisation of cutting-edge biotechnology. It signals continued momentum in bringing deeptech innovations from laboratories to practical application, particularly in critical sectors like health, food, and energy, thereby contributing to the EU's strategic objectives for a sustainable and competitive bioeconomy.